These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17163450)

  • 1. CD8+ suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65.
    James EA; Kwok WW
    Eur J Immunol; 2007 Jan; 37(1):78-86. PubMed ID: 17163450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
    Danke NA; Yang J; Greenbaum C; Kwok WW
    J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoreactive T cells in human type 1 diabetes.
    Tree TI; Peakman M
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation and expansion of regulatory human CD4(+) T-cell clones specific for pancreatic islet autoantigens.
    Dromey JA; Lee BH; Yu H; Young HE; Thearle DJ; Jensen KP; Mannering SI; Harrison LC
    J Autoimmun; 2011 Feb; 36(1):47-55. PubMed ID: 21050716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
    Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
    Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation.
    Câmara NO; Sebille F; Lechler RI
    Eur J Immunol; 2003 Dec; 33(12):3473-83. PubMed ID: 14635058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive T cells in healthy individuals.
    Danke NA; Koelle DM; Yee C; Beheray S; Kwok WW
    J Immunol; 2004 May; 172(10):5967-72. PubMed ID: 15128778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65.
    Oling V; Geubtner K; Ilonen J; Reijonen H
    Autoimmunity; 2010 Dec; 43(8):573-82. PubMed ID: 20370569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers.
    Learn CA; Fecci PE; Schmittling RJ; Xie W; Karikari I; Mitchell DA; Archer GE; Wei Z; Dressman H; Sampson JH
    Clin Cancer Res; 2006 Dec; 12(24):7306-15. PubMed ID: 17189402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.
    Wu Y; Farrell J; Pirmohamed M; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2007 Apr; 119(4):973-81. PubMed ID: 17320939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.